Annals of the New York Academy of Sciences · 2000 · 10 citations · 13 references
Life SciencesImmunologyPathologyImmunopathologyInflammationMucosal ImmunologyGastrointestinal ImmunologyGastrointestinal InflammationInflammatory SignalingIntestinal Barrier FunctionMucosal ImmunityMucosal InflammationColonic InflammationColonic PathologyCytokine-mediated Barrier DysfunctionGut Epithelial Barrier FunctionIntestinal Epithelial Barrier FunctionIntestinal Mucosal InjuryNitric OxideNitric Oxide Biology
On the basis of recently observed high levels of iNOS expression that correlated with intestinal inflammation in interleukin-2-deficient [IL-2(-/-)] mice, it was postulated that nitric oxide may damage colonic epithelial cells or impair intestinal epithelial barrier function. This damage may result in an increased permeability of the colonic epithelium leading to high antigenic exposure of the intestinal immune system, which may perpetuate chronic inflammation. Our data demonstrate that high expression of iNOS in IL-2(-/-) mice is correlated with the length/weight ratio (L/W ratio), a widely accepted marker for intestinal inflammation. However, no reduction of epithelial resistance was observed, as would be expected in case of a damaged, leaky epithelium. Our results suggest that enhanced formation of NO in IL-2(-/-) mice does not cause impairment of epithelial barrier function.
13
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Benjamin Sadlack, Hartmut Merz, Hubert Schorle et al. · Cell · 1993 · 1.7K citations
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
N. K. Boughton-Smith, Sue Evans, Brendan J.R. Whittle et al. · The Lancet · 1993 · 471 citations